Pathogenic microorganism growth inhibition via antimicrobial metabolite production

This entry describes a mechanism by which certain organisms (typically bacteria or fungi) inhibit the growth of pathogenic microorganisms through the production and secretion of antimicrobial metabolites, often secondary metabolites such as lipopeptides (surfactin, fengycin, iturin), thiazoles, or other small molecules. These metabolites can act by disrupting cell membranes, forming ion channels, generating reactive oxygen species, or inhibiting biosynthetic pathways in target microbes[1][2]. This is not a molecule or receptor but a descriptor for a class of activities central to natural antimicrobial defense and competition in microbial communities. It is a process rather than a therapeutic target. The term does **not correspond to a canonical single molecule or gene product** and should not be used as a target identifier for receptor-, enzyme-, or transporter-focused research or drug development.

Other names

antimicrobial metabolite-mediated inhibitionantimicrobial secondary metabolite productiongrowth inhibition via antibiotics

Disruption of microbial membrane integrity, Inhibition of nucleic acid/protein synthesis, Ion channel formation, Production of reactive oxygen species[2]